Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients

(2012) S. F. J. Whelan et al.   BLOOD

von Willebrand factor: the old, the new and the unknown

(2012) P. J. LENTING et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Factor VIII and Platelets Synergistically Accelerate Cleavage of von Willebrand Factor by ADAMTS13 under Fluid Shear Stress

(2010) Christopher G. Skipwith et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Structure and Function of a Recombinant von Willebrand Factor Drug Candidate

(2010) Peter Turecek et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF

(2009) S. Zanardelli et al.   BLOOD

Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factor

(2009) K. VARADI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients

(2009) Kathelijn Fischer et al.   PLoS One

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura

(2008) J. E. Sadler   BLOOD

Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13

(2008) W. Cao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA